Tous les communiqués | WebDisclosure

Switch to English

11086	Sociétés
243508	Mots-clés
171682	Articles
131185	Communiqués

Accueil
Tous les communiqués

COMMUNIQUÉ DE PRESSE

publié le 11/12/2025 à 07:00, il y a 9 mois 17 jours

AM Best confirms the rating of Helvetia Swiss Insurance Company Ltd with stable outlook and removes “under review” status
AM Best confirms Helvetia Swiss Insurance Company Ltd's A (Excellent) rating with stable outlook post-merger with Baloise. Strong balance sheet, diversified performance, and market leadership contribute to stable outlook

Insurance Merger Rating Helvetia AM Best
COMMUNIQUÉ DE PRESSE

publié le 11/12/2025 à 07:00, il y a 9 mois 17 jours

DKSH Performance Materials Scales its Food and Beverage Business in New Zealand and Australia by Acquiring Invita
DKSH Performance Materials enhances food and beverage business in New Zealand and Australia by acquiring Invita, securing a leading distributor in the region

Acquisition Food And Beverage Performance Materials DKSH Invita
COMMUNIQUÉ DE PRESSE

publié le 11/12/2025 à 07:00, il y a 9 mois 17 jours

BioVersys Announces BV100 Phase 3 Initiation and Provides a Business Update
BioVersys AG initiates BV100 Phase 3 study for ventilator-associated bacterial pneumonia, achieving significant milestones in 2025 and upcoming key events in 2026

Clinical Trials Biopharmaceutical BioVersys AG BV100 Phase 3 Ventilator Associated Bacterial Pneumonia
COMMUNIQUÉ DE PRESSE

publié le 11/12/2025 à 07:00, il y a 9 mois 17 jours

SCHOTT Pharma delivers on full-year revenue and profitability targets
SCHOTT Pharma met full-year revenue and profitability targets, with revenue growing by 5.8% and EBITDA margin at 28.4%. Fiscal year 2026 guidance: 2-5% revenue growth and 27% EBITDA margin

Revenue Growth EBITDA Margin SCHOTT Pharma Profitability Targets Fiscal Year 2026
COMMUNIQUÉ DE PRESSE

publié le 11/12/2025 à 07:00, il y a 9 mois 17 jours

Carl Zeiss Meditec closes fiscal year 2024/25 with solid growth in revenue and slight increase in EBITA
Carl Zeiss Meditec closes fiscal year 2024/25 with solid revenue growth of 7.8% and slight increase in EBITA. Order intake and backlogs also show positive trends

Financial Results Revenue Growth Order Intake Carl Zeiss Meditec EBITA
COMMUNIQUÉ DE PRESSE

publié le 11/12/2025 à 07:00, il y a 9 mois 17 jours

Inside Information / Other news releases
Innate Pharma releases its 2026 financial calendar, including key dates for financial statements and shareholder meetings. Find details on the company's website

Euronext Financial Calendar Nasdaq Innate Pharma 2026
COMMUNIQUÉ DE PRESSE

publié le 11/12/2025 à 07:00, il y a 9 mois 17 jours

Informations privilégiées / Autres communiqués
Innate Pharma publie son calendrier financier pour 2026, incluant la publication des résultats annuels et semestriels, ainsi que des chiffres d'affaires trimestriels

Chiffre D'affaires Calendrier Financier Résultats Annuels Innate Pharma Immunothérapies
COMMUNIQUÉ DE PRESSE

publié le 11/12/2025 à 07:00, il y a 9 mois 17 jours

Inside Information / Other news releases
Antin Infrastructure Partners to acquire NorthC Datacenters, a major European enterprise colocation data centre platform, from DWS and expand its presence in Northwest Europe

Digital Infrastructure Antin Infrastructure Partners NorthC Datacenters Colocation Data Centre DWS
COMMUNIQUÉ DE PRESSE

publié le 11/12/2025 à 07:00, il y a 9 mois 17 jours

Communiqué de presse : Qfitlia et Cablivi de Sanofi approuvés en Chine, élargissant la prise en charge des maladies rares
Sanofi voit Qfitlia et Cablivi approuvés en Chine pour traiter les maladies rares, marquant une avancée significative avec des approbations récentes dans le domaine de l'hématologie

Chine Sanofi Maladies Rares Qfitlia Cablivi
COMMUNIQUÉ DE PRESSE

publié le 11/12/2025 à 07:00, il y a 9 mois 17 jours

Press Release: Sanofi’s Qfitlia and Cablivi approved in China, expanding care for rare diseases
Sanofi's Qfitlia and Cablivi have been approved in China by the National Medical Products Administration, expanding care for rare diseases in the country. Qfitlia offers protection for hemophilia with as few as six injections a year, while Cablivi targets a rare life-threatening blood clotting disorder

China Sanofi Rare Diseases Qfitlia Cablivi

Les Echos

Publié le 28/09/2026 à 17:54, il y a 8 heures

Reporting on share buyback transactions carried out between September 21 and September 25, 2026
Publié le 28/09/2026 à 17:54, il y a 8 heures

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 21 et le 25 septembre 2026
Publié le 28/09/2026 à 17:45, il y a 8 heures 10 minutes

Weekly share buyback
Publié le 28/09/2026 à 17:45, il y a 8 heures 10 minutes

Déclaration hebdomadaire de rachat d'actions
Publié le 28/09/2026 à 17:35, il y a 8 heures 20 minutes

Déclaration hebdomadaire d'opérations effectuées du 21 au 25 septembre 2026

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 29/09/2026 à 00:00, il y a 1 heure 55 minutes

Medicure Announces Completion of Enrollment in Its MEND-PNPO Phase 3 Clinical Trial
Publié le 28/09/2026 à 23:00, il y a 2 heures 55 minutes

CORRECTION FROM SOURCE: Organto Foods Highlights Record First Half Results and Progress on Key Strategic Initiatives
Publié le 28/09/2026 à 15:00, il y a 10 heures 55 minutes

Vox to Acquire Silver Royalty over the Sorby Hills Project in Australia
Publié le 28/09/2026 à 14:45, il y a 11 heures 10 minutes

Clinical Trial of the Oral Drug NV-387 to Treat Ebola Has Started Enrollment and Dosing of Patients Last Week (on or about September 23rd), Says NanoViricides
Publié le 28/09/2026 à 14:30, il y a 11 heures 25 minutes

Drilling at Cat Creek Intersects a Copper-Molybdenum Porphyry System Visible Molybdenite-Chalcopyrite Over Significant Core Widths

Voir tout ACCESSWIRE

EQS Group

Publié le 28/09/2026 à 22:14, il y a 3 heures 40 minutes

EQS-Adhoc: Extension of the Managing Directors' employment contracts of Carsten Cramer, Lars Ricken and Thomas Treß – Carsten Cramer appointed Chairman of the Management Board
Publié le 28/09/2026 à 19:24, il y a 6 heures 30 minutes

EQS-Adhoc: Hapag-Lloyd further raises its earnings outlook for the current financial year
Publié le 28/09/2026 à 19:00, il y a 6 heures 54 minutes

PATRIMOINE ET COMMERCE : Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 21 septembre 2026 au 25 septembre 2026
Publié le 28/09/2026 à 18:00, il y a 7 heures 54 minutes

GEVELOT S.A.: Weekly declaration of share buybacks – 09/28/2026 (French only)
Publié le 28/09/2026 à 18:00, il y a 7 heures 54 minutes

GEVELOT S.A.: Déclaration hebdomadaire de rachat d'actions 28/09/2026